Effectiveness of natural-based products for radiation-induced oral mucositis therapy: A systematic review

被引:2
作者
Pranadwista, Zulfa Fidi [1 ]
Nur'aeny, Nanan [2 ]
机构
[1] Padjadjaran State Univ, Fac Dent, Oral Med Specialist Study Program, Bandung 40132, ID, Indonesia
[2] Padjadjaran State Univ, Fac Dent, Dept Oral Med, Bandung 40132, ID, Indonesia
关键词
Radiation therapy; Oral mucositis; Natural-based products; DOUBLE-BLIND; CANCER-PATIENTS; TRIPLE-BLIND; MANUKA HONEY; NECK-CANCER; PHASE-III; PLACEBO; HEAD; MANAGEMENT; EFFICACY;
D O I
10.1016/j.ctarc.2023.100720
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Radiation-induced oral mucositis (RIOM) is one of the common toxic reactions from ionizing radiation and normal tissue injuries as a complication of radiation therapy and chemotherapy. Radiation therapy is an option for the treatment of head and neck cancer (HNC). The use of natural products is an alternative therapy for RIOM. This review aimed to describe the effectiveness of natural-based products (NBPs) in reducing the severity, pain score, incidence, oral lesion size, and other symptoms such as dysphagia, dysarthria, and odynophagia. This systematic review follows the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) guidelines. Pubmed, ScienceDirect, and Ebscohost-CINAHL Plus databases were used for article searches. The inclusion criteria were studies published from 2012 to 2022 with full text available, in English, a study in humans, and a Randomized Clinical Trial (RCT) that evaluate the effect of NBPs therapy in RIOM patients diagnosed with HNC. This study's population was HNC patients who had oral mucositis after receiving radiation or chemical therapy. The NBPs were manuka honey, thyme honey, aloe vera, calendula, zataria multiflora, Plantago major L., and turmeric. Eight of the twelve included articles showed significant effectiveness against RIOM in various parameters, such as a decrease in severity, incidence rate, pain score, oral lesion size, and the other symptoms of oral mucositis such as dysphagia and burning mouth syndrome. This review concludes that NBPs therapy is effective for RIOM in HNC patients.
引用
收藏
页数:7
相关论文
共 37 条
  • [1] Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA. Cancer J. Clin., 68, 6, pp. 394-424, (2018)
  • [2] Elsabagh H.H., Moussa E., Mahmoud S.A., Elsaka R.O., Abdelrahman H., Efficacy of Melatonin in prevention of radiation-induced oral mucositis: a randomized clinical trial, Oral Dis., 26, 3, pp. 566-572, (2020)
  • [3] Maria O.M., Eliopoulos N., Muanza T., Radiation-induced oral mucositis, Front. Oncol., 7, 89, pp. 1-23, (2017)
  • [4] Daugelaite G., Uzkuraityte K., Jagelaviciene E., Filipauskas A., Prevention and treatment of chemotherapy and radiotherapy induced oral mucositis, Medicina (Kaunas), 55, 2, pp. 1-14, (2019)
  • [5] DDS B.N., Damm DDS D.D., Allen DDSMSD C.M., Chi DMD A.C., Oral and Maxillofacial Pathology, (2015)
  • [6] Ebert N., Et al., Results of a randomized controlled phase III trial: efficacy of polyphenol-containing cystus® tea mouthwash solution for the reduction of mucositis in head and neck cancer patients undergoing external beam radiotherapy, Strahlentherapie und Onkol, 197, 1, pp. 63-73, (2021)
  • [7] Oral S.C., Medicine M., The Basis of Diagnosis and Treatment, pp. 372-373, (2013)
  • [8] Shah S., Rath H., Sharma G., Senapati S.N., Mishra E., Effectiveness of curcumin mouthwash on radiation-induced oral mucositis among head and neck cancer patients: a triple-blind, pilot randomised controlled trial, Indian J. Dent. Res., 31, 5, pp. 718-727, (2020)
  • [9] Delavarian Z., Et al., Oral administration of nanomicelle curcumin in the prevention of radiotherapy-induced mucositis in head and neck cancers, Spec. Care Dent., 39, 2, pp. 166-172, (2019)
  • [10] Farah C.S., Balasubramaniam R., McCullough M.J., Contemporary Oral Medicine: A Comprehensive Approach to Clinical Practice, pp. 2197-2198, (2019)